12 Apr Chemotherapy Proves Life-Saving for Some Leukemia Patients Who Fail Induction Therapy
Newswise — (MEMPHIS, Tenn. – April 11, 2012) An international study found that bone marrow transplants are not the best option...26 Oct Through-the-Nipple Breast Cancer Therapy Shows Promise in Early Tests
October 26 2011 Newswise — Delivering anticancer drugs into breast ducts via the nipple is highly effective in animal models...26 Oct Gene responsible for relapses in young leukemia patients
One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia...06 Oct Tyk2 protein potential new Breast Cancer Therapy Target
New Rochelle, NY, October 5, 2011 — A possible new target for breast cancer therapy comes from the discovery that...02 Sep Key function of mutation in BRCA1 gene discovered
Richmond, Va. (September 1, 2011) –It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly...11 Aug Team reports genetic sequences most common bladder cancer
August 11, 2011 (Aurora, CO)–In an article published online this week in Nature Genetics, a University of Colorado Cancer Center...04 Aug Scientists map genetic mutations in the second-most common form of brain cancer, oligodendroglioma
Posted at 18:44h
in Brain Cancer - Brain Tumors
Johns Hopkins Kimmel Cancer Center scientists have completed a comprehensive map of genetic mutations occurring in the second-most common form...
26 Jul New Avenues Open Up for Mesothelioma Targeted Therapy
Posted at 00:12h
in Cancer Research
Newswise — July 25, 2011 (Philadelphia, PA) –Researchers from the lab of Antonio Giordano, M.D., Ph.D., the Founder and Director...
24 Jul 2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma
A genome-wide association study published in the August issue of Nature Medicine has found two tiny genetic variations that can...
13 Oct The challenge of cartilage repair
The progress in viral vector manufacturing and gene editing means orthopedic specialists may soon be able to offer treatments that genuinely restore cartilage, not just mask symptoms. Ongoing developments focus on increasing the specificity of gene delivery, enhancing the durability of therapeutic effects, and scaling up production methods to allow widespread clinical adoption.
17 Sep Inside the Longevity World Cup’s Quest to Delay Aging
Longevity science is a proactive approach to the universal problem of disease and aging. It no longer makes sense to wait until someone is old and grey to spend tons of money managing a disease that could’ve been avoided altogether. Instead, longevity experts recommend lifestyle changes and scientific interventions to prevent the onset of the disease in the first place.
04 Feb The Future of Tinnitus Treatment: Breakthroughs That Could Silence the Noise
Posted at 11:17h
in Hearing Loss
Treatment for tinnitus is advancing beyond symptom management. Innovations in neuromodulation, regenerative medicine, and AI-driven therapies are creating new possibilities that could redefine how the condition is treated.
28 Jan Roswell Parks Opens Largest Engineering and Cell Manufacturing Facility to Expand Cancer Research
MedicalResearch.com Interview with: Christopher Choi, PhD, MBA Senior Vice President of Industry Partnerships Associate Professor of Oncology Technical Director of...
25 Jul Funding Breakthroughs: How Financial Incentives Drive Medical Innovation
Posted at 12:11h
in Pharmaceutical Companies
There are ways to make getting funding easier and more effective. One idea is to simplify the application process for grants and tax credits. This could help more small companies and new researchers get support. Some countries are already doing this.
25 Jul HAE Treatment: Weighing the Benefits and Risks for Individual Patients
Posted at 10:52h
in Dermatology
Managing HAE involves balancing benefits and risks. Each patient requires a personalized
approach. Regular monitoring and patient feedback are key
29 Jun Clincierge Personalizes Patient Support Services to Facilitate Clinical Trials
Posted at 00:00h
in Author Interviews
The team at Clincierge is very conscious of the need to expand the diversity profile of patients included in clinical trials. We do this by first identifying the particular barriers to access that deter participants, such as emotional, physical, and financial considerations. Then we create strategies to address them head-on.
12 Jan Short Telomeres LInked to More Severe COVID-19 Disease
Those patients that have the more severe disease including severe respiratory distress tend to have shorter telomeres than those with longer telomeres.
27 Apr CRISPR-Edited Stem Cells Cured Diabetes in a Mouse Model
Our study suggests that we may be able to cure monogenic diseases, especially monogenic diabetes (i.e., diabetes caused by gene mutations) and monogenic retinal degeneration, using gene editing in combination with patient-derived iPSCs.
07 Apr Single-Dose, Intranasal Vaccine with Recombinant Virus May Block COVID-19
A similar approach could be tested against the SARS-CoV-2 that is associated with the current pandemic.01 Jun Engineered Single Cell ‘Cured’ Patient of CLL
Posted at 23:27h
in Author Interviews, Cancer Research, Leukemia, Nature, University of Pennsylvania
MedicalResearch.com Interview with: Dr. J Joseph Melenhorst, PhD Director, Product Development & Correlative Sciences laboratories (PDCS) Adjunct Associate Professor Penn...